Pfizer passes COVID-19 vaccine safety milestone, reveals 95% efficacy ahead of EUA

Pfizer passes COVID-19 vaccine safety milestone, reveals 95% efficacy ahead of EUA

Source: 
Fierce Biotech
snippet: 

Pfizer is preparing to file its COVID-19 vaccine for emergency use authorization (EUA) after passing a key safety milestone. CEO Albert Bourla, Ph.D., said Pfizer now has the median two-month follow-up data needed to secure EUA from the FDA, putting it a step closer to bringing its vaccine to market in the U.S.